More importantly, the increase in AFP-L3 can further rule out the possibility of other liver diseases, such as hepatitis and cirrhosis, thereby reducing the false-positive results of AFP in the diagnosis of HCC 27-28. This evidence concerns the gene AFP and hepatocellular carcinoma.